Telomerase activity for the preoperative diagnosis of pancreatic cancer.

[1]  J. Lee,et al.  Telomerase Activity in Human Breast Tumors , 1998 .

[2]  H. Reber,et al.  Diagnostic workup of patients with suspected pancreatic carcinoma , 1997, Cancer.

[3]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[4]  G. Shyamala.  Roles of Estrogen and Progesterone in Normal Mammary Gland Development Insights from Progesterone Receptor Null Mutant Mice and In Situ Localization of Receptor , 1997, Trends in Endocrinology & Metabolism.

[5]  J. Shay,et al.  Telomerase activity is detected in pancreatic cancer but not in benign tumors. , 1997, Cancer research.

[6]  J. Meyer,et al.  Marked regression of a nonpalpable breast cancer after cessation of hormone replacement therapy. , 1996, AJR. American journal of roentgenology.

[7]  K. Hanada,et al.  Immunocytochemical detection of p53 protein from pancreatic duct brushings in patients with pancreatic carcinoma , 1996, Cancer.

[8]  S. Taplin,et al.  Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. , 1996, Journal of the National Cancer Institute.

[9]  M. Cohen,et al.  Fine-needle aspiration of the pancreas. , 1996, Pathology.

[10]  E A Sickles,et al.  Management of probably benign breast lesions. , 1995, Radiologic clinics of North America.

[11]  J. Shay,et al.  Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. , 1995, Journal of immunology.

[12]  E B Larson,et al.  Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. , 1995, Radiology.

[13]  A. Gazdar,et al.  Telomerase activity in small-cell and non-small-cell lung cancers. , 1995, Journal of the National Cancer Institute.

[14]  J. Shay,et al.  Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP) , 1995 .

[15]  K. Lillemoe.  Current Management of Pancreatic Carcinoma , 1995, Annals of surgery.

[16]  L. Green,et al.  Fine needle aspiration of the pancreas. In quest of accuracy. , 1995, Acta cytologica.

[17]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[18]  D. Macerlaine,et al.  Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study. , 1994, AJR. American journal of roentgenology.

[19]  D. Cyrlak,et al.  Mammographic changes in postmenopausal women undergoing hormonal replacement therapy. , 1993, AJR. American journal of roentgenology.

[20]  N. Estes,et al.  Breast biopsy for nonpalpable lesions: a worthwhile endeavor? , 1993, The American surgeon.

[21]  A. Yanagisawa,et al.  Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. , 1993, Cancer research.

[22]  M. Omata,et al.  Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. , 1991, Gastroenterology.

[23]  P. Stomper,et al.  Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. , 1990, Radiology.

[24]  J. Berkowitz,et al.  Hormonal replacement therapy: mammographic manifestations. , 1990, Radiology.

[25]  G. Morin.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats , 1989, Cell.

[26]  Donald E. Henson,et al.  Manual for Staging of Cancer, 3rd edition , 1988 .

[27]  E. Sickles.  Mammographic features of 300 consecutive nonpalpable breast cancers. , 1986, AJR. American journal of roentgenology.

[28]  E A Sickles,et al.  Mammographic features of "early" breast cancer. , 1984, AJR. American journal of roentgenology.

[29]  K. Gajl-Peczalska,et al.  Cytologic studies for the diagnosis of pancreatic cancer , 1981, Cancer.